Thierry Legon
5Patents
2h-index
9Co-inventors
40Inventor score
Filing activity: Jun 25, 2001 → Jun 15, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6709672B2 | Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8735122B2 | Method for the purification of heat shock proteins | Chemistry; Metallurgy | 2 | Active |
| US7893250B2 | Demethylated and/or oxidized membrane DNA | Chemistry; Metallurgy | 0 | Active |
| US10195276B2 | Method for the production of hydrolyzed allergens | Chemistry; Metallurgy | 0 | Active |
| US8436136B2 | Peptide complex | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.